EP-1373: Hypofractionated radiotherapy and androgen deprivation in intermediate risk prostate cancer. (April 2016) - Bracci, S.; Osti, M.F.; Agolli, L.; Bertaccini, L.; De Sanctis, V.; Valeriani, M.